Alterations in NF-κ B Function in Transgenic Epithelial Tissue Demonstrate a Growth Inhibitory Role for NF-κ B

Stratified epithelium contains a mitotically active basal layer of cells that cease proliferating, then migrate outwards and undergo terminal differentiation. The control of this process, which is abnormal in cutaneous neoplasia and inflammation, is not well understood. In normal epidermis, NF-κ B p...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 95; no. 5; pp. 2307 - 2312
Main Authors Seitz, Cornelia S., Lin, Qun, Deng, Helen, Khavari, Paul A.
Format Journal Article
LanguageEnglish
Published National Academy of Sciences of the United States of America 03.03.1998
National Acad Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Stratified epithelium contains a mitotically active basal layer of cells that cease proliferating, then migrate outwards and undergo terminal differentiation. The control of this process, which is abnormal in cutaneous neoplasia and inflammation, is not well understood. In normal epidermis, NF-κ B proteins were found to exist in the cytoplasm of basal cells and then to localize in the nuclei of suprabasal cells, suggesting a role for NF-κ B in the switch from proliferation to growth arrest and differentiation. Functional blockade of NF-κ B by expressing dominant-negative NF-κ B inhibitory proteins in transgenic murine and human epidermis produced hyperplastic epithelium in vivo. Consistent with this, application of a pharmacologic inhibitor of NF-κ B to intact skin induced epidermal hyperplasia. In contrast, overexpression of active p50 and p65 NF-κ B subunits in transgenic epithelium produced hypoplasia and growth inhibition. These data suggest that spatially restricted NF-κ B activation occurs in stratified epithelium and indicate that NF-κ B activation in this tissue, in contrast to its role in other settings, is important for cellular growth inhibition.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Edited by Elaine V. Fuchs, University of Chicago, Chicago, IL, and approved December 23, 1997
To whom reprint requests should be addressed at: Stanford University School of Medicine, P204, MSLS, Stanford, CA 94305. e-mail: khavari@CMGM.stanford.edu.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.95.5.2307